Abstract
Today, lung cancer occupies one of the leading positions in the structure of cancer morbidity and mortality in Russia. Unfortunately, in the vast majority of cases, patients have a widespread process at the time of diagnosis. According to the histological variant, non-small cell cancer prevails among the detected malignant lung tumors. Due to the aggressiveness of the tumor and the latent course of the disease, up to 70% of patients at the time of diagnosis have stages III (30.5%) and IV (39.8%). The treatment of patients with locally advanced non-small cell lung cancer continues to be a subject of research and debate. Surgery remains the radical method of treating lung cancer, but long-term results have not changed significantly over the past decades and are directly dependent on the stage of the disease and the histological structure of the tumor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
